Nephrology Associates of Northern Illinois and Indiana


Contact : +1-630-573-5000

NANI Clinical Trials, Clinical Research, NANI Nephrology Associates of Northern Illinois and Indiana, Nephrology Associates of Northern Illinois and Indiana

Clinical Research 




Clinical Trials are the gateway to advances in the field of Medicine.

Clinical Trials, Clinical Research, NANI Nephrology Associates of Northern Illinois and IndianaNANI Research conducts high-quality Phase II-IV clinical trials at many NANI locations, specializing research for the field of Nephrology. We are affiliated with Nephrology Associates of Northern Illinois / Indiana (NANI).   NANI employs more than 120 board-certified nephrologists and has a large database of patients in facilities around Chicago and Northern Indiana. NANI Research conducts trials for many Pharmaceutical Companies, Contract Research Organizations and biotechnology companies.

About us

NANI has set a high standard for the conduct of Clinical Trials. We provide a reliable environment in which clinical research of superior quality is conducted. All personnel involved in conducting Clinical Trials at NANI are trained with a set of Standard Operating Procedures to ensure a uniformity, dependability and quality of Clinical Trial conduction and data collection.

Expertise

NANI is a dedicated Nephrology Facility. Our research expertise includes some of the following:

If you are a patient, sponsor or NANI physician interested in research, contact us to get involved:

NANI Research
Ph: 331-216-1115
Email us to request more information:
Include your name, phone and a message requesting more information at About NANI Research. 
Send inquiries to Nancy Cipparrone, Director of Research.



 Our Team

Clinical trials at our facilities are run by kidney doctors, or nephrologists. Our physician investigators are trained in the Code of Federal Regulations and International Conference on Harmonization Guidelines and are Good Clinical Practice certified.

Dr. Amit Arora

Dr. Sumit Bector

Dr. Venkata Behara

Dr. Nayan Gowda

Dr. Prasanna Isaac

Dr. Kevin Myrie

Dr. Andrew O’Shaughnessy

Dr. Andrew Peck

Dr. Suneel Udani

Dr. Thomas Golubski

Dr. Omaima Degani

Dr. Leon Sujata

Research Team:

The NANI Research Team is responsible for conducting clinical trials within the Code of Federal Regulations and International Conference Harmonization guidelines. Team members are thoroughly trained and regularly monitored for compliance to all NANI Standard Operating Procedures and Good Clinical Practice Guidelines.

  • Nancy Cipparone
  • Swarnam Chiramel
  • Aaron Staller
  • Christopher Tokarczyk
  • Kristine Valcarcel
  • Jesse Villalobos


 Current Trials

Open Enrolling Studies:

A Phase 2a Multiple Ascending, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GFB-887, a TRPC5 Channel Inhibitor, in Patients with Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease. For more information please go to the clinical trials website

Closed to Enrollment:

Check back for ongoing updates.



 For Potential Research Participants

Clinical Research is the foundation for advancement of medicine, offering new ways to prevent, detect and treat diseases. Clinical Trials have offered hope for people with chronic illnesses and the possibility of new kidney disease treatments in the future. Our research participants help us make this happen.

Why participate in a Clinical Trial?

The decision to enroll in research is personal.  For some, clinical trial participation may offer new investigational treatment options and hope of recovery from illness.  For others, it’s a way to help people in the future.  Most importantly, everyone receives skilled and compassionate care at NANI.

People who participate in research are closely monitored by physicians and research team members during their clinical trial participation.  Our researchers ensure participants and families are kept informed throughout the trial and remain available for questions and additional support.

We offer research opportunities for adult individuals at sites of care throughout Chicagoland and Northwest Indiana.

How does it work?

Before a drug can be released and sold in the consumer market, there are many levels of approval needed. Clinical Trials are conducted to collect the data regarding overall safety and efficacy of a new drug during its development. This testing begins in the laboratory. It involves months of experimentation on animal and human cells before it reaches trial on humans. If these initial experiments are successful, the accumulated data is then sent to the FDA for approval to continue research in humans. This commences the 4 phases of a Clinical Trial. NANI conducts only Phase II, III and IV Clinical Trials.

Phase I: A new drug/treatment is tested in a small group of healthy individuals to evaluate the safety, tolerability, side effects and safe dosage.

Phase II: The same drug is given to a larger group of individuals to further determine its effectiveness, safety and overall, how well the drug works.

Phase III: The same drug is then given to even larger groups to confirm its effectiveness, side effects, and compare it to current “gold-standard” treatments already in the market.

Phase IV: After the drug/treatment has released in the market, studies are done to collect information on the drug’s effects in various populations and associated side effects with long-term usage.




 For Sponsors

NANI Research specializes in conducting high-quality Phase II-IV Clinical Trials in Nephrology at many of its NANI Clinic Locations, with access to thousands of Nephrology patients having varying common and rare diagnoses.

NANI successfully works with many Sponsors and CROs and their staff. We have productive working relationships with clinical research associates, on-site and remote, clinical trial managers, laboratories, vendors, and hospitals.

NANI implements a GCP, 21 CFR Part 11 compliant Clinical Trial Management System with e-regulatory, e-source, and e-consent capabilities making it accessible to Sponsor’s and CROs to participate in remote monitoring.

NANI Research can open a clinical trial from CDA execution to SIV in less than 8 weeks and we work with many commercial IRBs. Our research sites offer full service phlebotomy, investigational product handling, laboratory processing / shipping, and other ancillary services.

NANI Research ILLINOIS locations:
  • 601 W Golf Rd, Ste 105 Mt. Prospect, IL 60056
  • 1445 Hunt Club Drive, Suite 201 Gurnee, IL 60031
  • 390 Congress Pkwy, Suite C 60014, Crystal Lake, IL 60014
  • 911 N. Elm St, Suite 102, Hinsdale, IL 60521
NANI Research INDIANA Locations:
  • 90 W 86th Ave, Merrillville IN 46410
  • 7836 W Jefferson Blvd, Ste 101, Fort Wayne IN 46804
All Research Sites Include:
  • On-site CLIA waiver for processing lab specimens
  • Locked cabinet/room for ambient medication
  • Calibrated min/max alarm notification thermometers
  • Standard refrigerator
  • -20 degree freezer with calibrated min/max 24 hour-alarm notification thermometer
  • -70 degree freezer available if needed
  • Calibrated centrifuge
  • Dedicated fax lines with email notification
  • EKG machines with printed interpretation
  • Calibrated Adult Scale and Stadiometer
  • High capacity copier
  • High Speed internet access for study staff and CRAs
  • General and customized source documents for every trial
  • Electronic data entry capabilities
  • EMR Validation according to 21 CFR 11.10 (a) standard